301130 西点药业
2024/06 - 中期2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)2.6065.2385.54310.44310.828
总资产报酬率 ROA (%)2.4054.8465.0549.0839.199
投入资产回报率 ROIC (%)2.5925.2035.50610.36710.781

边际利润分析
销售毛利率 (%)78.39780.26581.63283.65184.664
营业利润率 (%)22.15124.68020.40520.88920.691
息税前利润/营业总收入 (%)20.13323.42417.47219.81519.921
净利润/营业总收入 (%)18.95922.39715.94118.21017.373

收益指标分析
经营活动净收益/利润总额(%)83.10950.44184.04786.59685.289
价值变动净收益/利润总额(%)8.06918.72813.2992.0393.335
营业外收支净额/利润总额(%)-2.5274.564-3.366-0.782-0.538

偿债能力分析
流动比率 (X)11.16611.80218.1799.0796.750
速动比率 (X)10.63311.29317.6448.3126.242
资产负债率 (%)7.4827.9027.05111.8510.143
带息债务/全部投入资本 (%)-2.785-2.422-2.773-6.158-7.312
股东权益/带息债务 (%)-3,575.999-4,100.446-3,581.472-1,613.686-1,356.015
股东权益/负债合计 (%)1,236.5401,165.4611,318.141743.795600.344
利息保障倍数 (X)-13.677-9.613-7.700-21.734-30.210

营运能力分析
应收账款周转天数 (天)45.28951.15351.34345.35746.184
存货周转天数 (天)163.585194.413181.359180.265171.195